IBDEI0FR ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1326,0)
 ;;=W DIAGNOSES^23^97
 ;;^UTILITY(U,$J,358.4,1327,0)
 ;;=B DIAGNOSES^3^97
 ;;^UTILITY(U,$J,358.4,1328,0)
 ;;=G DIAGNOSES^8^97
 ;;^UTILITY(U,$J,358.4,1329,0)
 ;;=H DIAGNOSES^8^97
 ;;^UTILITY(U,$J,358.4,1330,0)
 ;;=L DIAGNOSES^12^97
 ;;^UTILITY(U,$J,358.4,1331,0)
 ;;=O DIAGNOSES^15^97
 ;;^UTILITY(U,$J,358.4,1332,0)
 ;;=U DIAGNOSES^21^97
 ;;^UTILITY(U,$J,358.4,1333,0)
 ;;=Z DIAGNOSES^25^97
 ;;^UTILITY(U,$J,358.4,1334,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^97
 ;;^UTILITY(U,$J,358.4,1335,0)
 ;;=MOST COMMON DX^1^97
 ;;^UTILITY(U,$J,358.4,1336,0)
 ;;=TELEHEALTH FACILITY FEE^1^98
 ;;^UTILITY(U,$J,358.4,1337,0)
 ;;=INFECTIOUS DISEASE^12^99
 ;;^UTILITY(U,$J,358.4,1338,0)
 ;;=NEOPLASMS^14^99
 ;;^UTILITY(U,$J,358.4,1339,0)
 ;;=HEMATOLOGY/ENDOCRINE^9^99
 ;;^UTILITY(U,$J,358.4,1340,0)
 ;;=MENTAL HEALTH^13^99
 ;;^UTILITY(U,$J,358.4,1341,0)
 ;;=NEUROLOGY^15^99
 ;;^UTILITY(U,$J,358.4,1342,0)
 ;;=GI^7^99
 ;;^UTILITY(U,$J,358.4,1343,0)
 ;;=CARDIOLOGY^3^99
 ;;^UTILITY(U,$J,358.4,1344,0)
 ;;=HERNIA^10^99
 ;;^UTILITY(U,$J,358.4,1345,0)
 ;;=GENITOURINARY^6^99
 ;;^UTILITY(U,$J,358.4,1346,0)
 ;;=SKIN^22^99
 ;;^UTILITY(U,$J,358.4,1347,0)
 ;;=ENT^4^99
 ;;^UTILITY(U,$J,358.4,1348,0)
 ;;=RHEUMATOLOGY/ORTHO^20^99
 ;;^UTILITY(U,$J,358.4,1349,0)
 ;;=RESPIRATORY^19^99
 ;;^UTILITY(U,$J,358.4,1350,0)
 ;;=SIGNS/SYMPTOMS/HX OF^21^99
 ;;^UTILITY(U,$J,358.4,1351,0)
 ;;=VASCULAR^24^99
 ;;^UTILITY(U,$J,358.4,1352,0)
 ;;=ANTICOAGULATION^2^99
 ;;^UTILITY(U,$J,358.4,1353,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^99
 ;;^UTILITY(U,$J,358.4,1354,0)
 ;;=ALLERGY/ASTHMA^1^99
 ;;^UTILITY(U,$J,358.4,1355,0)
 ;;=EYES^5^99
 ;;^UTILITY(U,$J,358.4,1356,0)
 ;;=HEADACHES^8^99
 ;;^UTILITY(U,$J,358.4,1357,0)
 ;;=IMMUNOLOGY^11^99
 ;;^UTILITY(U,$J,358.4,1358,0)
 ;;=NICOTINE DEPENDENCE^16^99
 ;;^UTILITY(U,$J,358.4,1359,0)
 ;;=PERSONAL HX/STATUS^18^99
 ;;^UTILITY(U,$J,358.4,1360,0)
 ;;=NEW PATIENT^2^100
 ;;^UTILITY(U,$J,358.4,1361,0)
 ;;=ESTABLISHED PATIENT^1^100
 ;;^UTILITY(U,$J,358.4,1362,0)
 ;;=CONSULTATIONS^3^100
 ;;^UTILITY(U,$J,358.4,1363,0)
 ;;=POST OP VISIT (GLOBAL)^4^100
 ;;^UTILITY(U,$J,358.4,1364,0)
 ;;=BONE MARROW^1^101
 ;;^UTILITY(U,$J,358.4,1365,0)
 ;;=HEART^2^101
 ;;^UTILITY(U,$J,358.4,1366,0)
 ;;=HEART-LUNG^3^101
 ;;^UTILITY(U,$J,358.4,1367,0)
 ;;=LIVER^4^101
 ;;^UTILITY(U,$J,358.4,1368,0)
 ;;=LUNG^5^101
 ;;^UTILITY(U,$J,358.4,1369,0)
 ;;=PANCREAS^7^101
 ;;^UTILITY(U,$J,358.4,1370,0)
 ;;=RENAL^9^101
 ;;^UTILITY(U,$J,358.4,1371,0)
 ;;=REPAIR/RESECTION OF DONOR HEART^10^101
 ;;^UTILITY(U,$J,358.4,1372,0)
 ;;=PROLONGED SERVICE^8^101
 ;;^UTILITY(U,$J,358.4,1373,0)
 ;;=MODERATE SEDATION^6^101
 ;;^UTILITY(U,$J,358.4,1374,0)
 ;;=CHRONIC PULM. HEART DISEASE^2^102
 ;;^UTILITY(U,$J,358.4,1375,0)
 ;;=DIS. OF BLOOD/FORMING ORGA^4^102
 ;;^UTILITY(U,$J,358.4,1376,0)
 ;;=HERNIA^7^102
 ;;^UTILITY(U,$J,358.4,1377,0)
 ;;=KIDNEY/PANCREAS^8^102
 ;;^UTILITY(U,$J,358.4,1378,0)
 ;;=LIVER^9^102
 ;;^UTILITY(U,$J,358.4,1379,0)
 ;;=LUNG^10^102
 ;;^UTILITY(U,$J,358.4,1380,0)
 ;;=MALIGNANT LYMPH & HEMATOP^11^102
 ;;^UTILITY(U,$J,358.4,1381,0)
 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^12^102
 ;;^UTILITY(U,$J,358.4,1382,0)
 ;;=METABOLIC DISORDERS^13^102
 ;;^UTILITY(U,$J,358.4,1383,0)
 ;;=SYMPTOMS/SIGNS^14^102
 ;;^UTILITY(U,$J,358.4,1384,0)
 ;;=COMPLICATIONS OF SURGERY^3^102
 ;;^UTILITY(U,$J,358.4,1385,0)
 ;;=DONORS OF ORGANS AND TISSUES^5^102
 ;;^UTILITY(U,$J,358.4,1386,0)
 ;;=HEART^6^102
 ;;^UTILITY(U,$J,358.4,1387,0)
 ;;=AFTERCARE FOLLOWING TRANSPLANT^1^102
 ;;^UTILITY(U,$J,358.4,1388,0)
 ;;=NEW PATIENT^2^103
 ;;^UTILITY(U,$J,358.4,1389,0)
 ;;=ESTABLISHED PATIENT^1^103
 ;;^UTILITY(U,$J,358.4,1390,0)
 ;;=POST-OP (GLOBAL)^3^103
 ;;^UTILITY(U,$J,358.4,1391,0)
 ;;=JOINT INJECTIONS^15^104
 ;;^UTILITY(U,$J,358.4,1392,0)
 ;;=TENDON INJECTION^26^104
 ;;^UTILITY(U,$J,358.4,1393,0)
 ;;=SKIN PROCEDURES^24^104
 ;;^UTILITY(U,$J,358.4,1394,0)
 ;;=ADMINISTRATION OF INJ MEDICATIONS^2^104
 ;;^UTILITY(U,$J,358.4,1395,0)
 ;;=EKG^11^104
 ;;^UTILITY(U,$J,358.4,1396,0)
 ;;=NOSEBLEEDS^16^104
 ;;^UTILITY(U,$J,358.4,1397,0)
 ;;=REMOVAL FB IN EAR^18^104
 ;;^UTILITY(U,$J,358.4,1398,0)
 ;;=INJECTABLE MEDICATIONS^14^104
 ;;^UTILITY(U,$J,358.4,1399,0)
 ;;=INFUSION MEDICATIONS^12^104
 ;;^UTILITY(U,$J,358.4,1400,0)
 ;;=ADMINISTRATION OF IV MEDICATIONS^3^104
 ;;^UTILITY(U,$J,358.4,1401,0)
 ;;=INHALATION SOLUTIONS THRU DME^13^104
 ;;^UTILITY(U,$J,358.4,1402,0)
 ;;=ADMINISTRATION OF DME^1^104
 ;;^UTILITY(U,$J,358.4,1403,0)
 ;;=DEMO OF METERED INHALER^10^104
 ;;^UTILITY(U,$J,358.4,1404,0)
 ;;=BLOOD TESTS^6^104
 ;;^UTILITY(U,$J,358.4,1405,0)
 ;;=BLADDER ^5^104
 ;;^UTILITY(U,$J,358.4,1406,0)
 ;;=BLOOD TRANSFUSION^7^104
 ;;^UTILITY(U,$J,358.4,1407,0)
 ;;=AIRWAY TREATMENTS^4^104
 ;;^UTILITY(U,$J,358.4,1408,0)
 ;;=BURN TREATMENT^8^104
 ;;^UTILITY(U,$J,358.4,1409,0)
 ;;=TB TEST^25^104
 ;;^UTILITY(U,$J,358.4,1410,0)
 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^20^104
 ;;^UTILITY(U,$J,358.4,1411,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^19^104
 ;;^UTILITY(U,$J,358.4,1412,0)
 ;;=REPAIR-INTERM-SCALP,TRUNK^23^104
 ;;^UTILITY(U,$J,358.4,1413,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^22^104
 ;;^UTILITY(U,$J,358.4,1414,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^21^104
 ;;^UTILITY(U,$J,358.4,1415,0)
 ;;=OTHER^27^104
 ;;^UTILITY(U,$J,358.4,1416,0)
 ;;=PSYCHIATRY^17^104
 ;;^UTILITY(U,$J,358.4,1417,0)
 ;;=COVID-19 RELATED^9^104
 ;;^UTILITY(U,$J,358.4,1418,0)
 ;;=PC COMMON DIAGNOSES^1^105
 ;;^UTILITY(U,$J,358.4,1419,0)
 ;;=ADMINISTRATIVE TOPICS^15^105
 ;;^UTILITY(U,$J,358.4,1420,0)
 ;;=ANGINA^16^105
 ;;^UTILITY(U,$J,358.4,1421,0)
 ;;=ATHEROSCLEROSIS^17^105
 ;;^UTILITY(U,$J,358.4,1422,0)
 ;;=CARDIOVASCULAR^18^105
 ;;^UTILITY(U,$J,358.4,1423,0)
 ;;=DERMATOLOGY^22^105
 ;;^UTILITY(U,$J,358.4,1424,0)
 ;;=EAR DISORDERS^24^105
 ;;^UTILITY(U,$J,358.4,1425,0)
 ;;=EENT^25^105
 ;;^UTILITY(U,$J,358.4,1426,0)
 ;;=ENDOCRINE/METABOLIC^26^105
 ;;^UTILITY(U,$J,358.4,1427,0)
 ;;=EYE DISORDERS^27^105
 ;;^UTILITY(U,$J,358.4,1428,0)
 ;;=EYE INJURY^28^105
 ;;^UTILITY(U,$J,358.4,1429,0)
 ;;=GASTROENTEROLOGY^29^105
 ;;^UTILITY(U,$J,358.4,1430,0)
 ;;=GU/RENAL^30^105
 ;;^UTILITY(U,$J,358.4,1431,0)
 ;;=HEADACHE^31^105
 ;;^UTILITY(U,$J,358.4,1432,0)
 ;;=HEART VALVE DISEASE^32^105
 ;;^UTILITY(U,$J,358.4,1433,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^105
 ;;^UTILITY(U,$J,358.4,1434,0)
 ;;=HISTORY OF ILLNESS^34^105
 ;;^UTILITY(U,$J,358.4,1435,0)
 ;;=INFECTIOUS DISEASE^35^105
 ;;^UTILITY(U,$J,358.4,1436,0)
 ;;=LIVER DISEASE^36^105
 ;;^UTILITY(U,$J,358.4,1437,0)
 ;;=MENTAL HEALTH^38^105
 ;;^UTILITY(U,$J,358.4,1438,0)
 ;;=MOVEMENT DISORDERS^39^105
 ;;^UTILITY(U,$J,358.4,1439,0)
 ;;=MUSCULOSKELETAL^40^105
 ;;^UTILITY(U,$J,358.4,1440,0)
 ;;=NEUROLOGY^41^105
 ;;^UTILITY(U,$J,358.4,1441,0)
 ;;=PAIN^42^105
 ;;^UTILITY(U,$J,358.4,1442,0)
 ;;=PREVENTIVE HEALTH^43^105
 ;;^UTILITY(U,$J,358.4,1443,0)
 ;;=PULMONARY^44^105
 ;;^UTILITY(U,$J,358.4,1444,0)
 ;;=SEXUAL TRAUMA^45^105
 ;;^UTILITY(U,$J,358.4,1445,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^105
 ;;^UTILITY(U,$J,358.4,1446,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^105
 ;;^UTILITY(U,$J,358.4,1447,0)
 ;;=SUBSTANCE DISORDERS^48^105
 ;;^UTILITY(U,$J,358.4,1448,0)
 ;;=VARICOSE VEINS^50^105
 ;;^UTILITY(U,$J,358.4,1449,0)
 ;;=WOMEN'S HEALTH^51^105
 ;;^UTILITY(U,$J,358.4,1450,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^105
 ;;^UTILITY(U,$J,358.4,1451,0)
 ;;=COMA^20^105
 ;;^UTILITY(U,$J,358.4,1452,0)
 ;;=CAUSES OF INJURY^19^105
 ;;^UTILITY(U,$J,358.4,1453,0)
 ;;=DEMENTIA^21^105
 ;;^UTILITY(U,$J,358.4,1454,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^105
 ;;^UTILITY(U,$J,358.4,1455,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^105
 ;;^UTILITY(U,$J,358.4,1456,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^105
 ;;^UTILITY(U,$J,358.4,1457,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^105
 ;;^UTILITY(U,$J,358.4,1458,0)
 ;;=ACSC ANGINA^4^105
 ;;^UTILITY(U,$J,358.4,1459,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^105
 ;;^UTILITY(U,$J,358.4,1460,0)
 ;;=ACSC CHF^6^105
 ;;^UTILITY(U,$J,358.4,1461,0)
 ;;=ACSC DEHYDRATION^7^105
 ;;^UTILITY(U,$J,358.4,1462,0)
 ;;=ACSC DIABETES TYPE 1^8^105
 ;;^UTILITY(U,$J,358.4,1463,0)
 ;;=ACSC DIABETES TYPE 2^9^105
 ;;^UTILITY(U,$J,358.4,1464,0)
 ;;=ACSC HYPERTENSION^10^105
 ;;^UTILITY(U,$J,358.4,1465,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^105
 ;;^UTILITY(U,$J,358.4,1466,0)
 ;;=ACSC PNEUMONIA^12^105
 ;;^UTILITY(U,$J,358.4,1467,0)
 ;;=ACSC UTI^13^105
 ;;^UTILITY(U,$J,358.4,1468,0)
 ;;=ACSC VIRAL ENTERITIS^14^105
 ;;^UTILITY(U,$J,358.4,1469,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^105
 ;;^UTILITY(U,$J,358.4,1470,0)
 ;;=HEALTH/BEHAVIOR ASSESSMENT^1^106
 ;;^UTILITY(U,$J,358.4,1471,0)
 ;;=HEALTH/BEHAVIOR INTERVENTION^2^106
 ;;^UTILITY(U,$J,358.4,1472,0)
 ;;=PC COMMON DIAGNOSES^1^107
 ;;^UTILITY(U,$J,358.4,1473,0)
 ;;=ADMINISTRATIVE TOPICS^15^107
 ;;^UTILITY(U,$J,358.4,1474,0)
 ;;=ANGINA^16^107
 ;;^UTILITY(U,$J,358.4,1475,0)
 ;;=ATHEROSCLEROSIS^17^107
 ;;^UTILITY(U,$J,358.4,1476,0)
 ;;=CARDIOVASCULAR^18^107
 ;;^UTILITY(U,$J,358.4,1477,0)
 ;;=DERMATOLOGY^22^107
 ;;^UTILITY(U,$J,358.4,1478,0)
 ;;=EAR DISORDERS^24^107
 ;;^UTILITY(U,$J,358.4,1479,0)
 ;;=EENT^25^107
 ;;^UTILITY(U,$J,358.4,1480,0)
 ;;=ENDOCRINE/METABOLIC^26^107
 ;;^UTILITY(U,$J,358.4,1481,0)
 ;;=EYE DISORDERS^27^107
 ;;^UTILITY(U,$J,358.4,1482,0)
 ;;=EYE INJURY^28^107
 ;;^UTILITY(U,$J,358.4,1483,0)
 ;;=GASTROENTEROLOGY^29^107
 ;;^UTILITY(U,$J,358.4,1484,0)
 ;;=GU/RENAL^30^107
 ;;^UTILITY(U,$J,358.4,1485,0)
 ;;=HEADACHE^31^107
 ;;^UTILITY(U,$J,358.4,1486,0)
 ;;=HEART VALVE DISEASE^32^107
 ;;^UTILITY(U,$J,358.4,1487,0)
 ;;=HEMATOLOGY/ONCOLOGY^33^107
 ;;^UTILITY(U,$J,358.4,1488,0)
 ;;=HISTORY OF ILLNESS^34^107
 ;;^UTILITY(U,$J,358.4,1489,0)
 ;;=INFECTIOUS DISEASE^35^107
 ;;^UTILITY(U,$J,358.4,1490,0)
 ;;=LIVER DISEASE^36^107
 ;;^UTILITY(U,$J,358.4,1491,0)
 ;;=MENTAL HEALTH^38^107
 ;;^UTILITY(U,$J,358.4,1492,0)
 ;;=MOVEMENT DISORDERS^39^107
 ;;^UTILITY(U,$J,358.4,1493,0)
 ;;=MUSCULOSKELETAL^40^107
 ;;^UTILITY(U,$J,358.4,1494,0)
 ;;=NEUROLOGY^41^107
 ;;^UTILITY(U,$J,358.4,1495,0)
 ;;=PAIN^42^107
 ;;^UTILITY(U,$J,358.4,1496,0)
 ;;=PREVENTIVE HEALTH^43^107
 ;;^UTILITY(U,$J,358.4,1497,0)
 ;;=PULMONARY^44^107
 ;;^UTILITY(U,$J,358.4,1498,0)
 ;;=SEXUAL TRAUMA^45^107
 ;;^UTILITY(U,$J,358.4,1499,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^107
 ;;^UTILITY(U,$J,358.4,1500,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^107
 ;;^UTILITY(U,$J,358.4,1501,0)
 ;;=SUBSTANCE DISORDERS^48^107
 ;;^UTILITY(U,$J,358.4,1502,0)
 ;;=VARICOSE VEINS^50^107
 ;;^UTILITY(U,$J,358.4,1503,0)
 ;;=WOMEN'S HEALTH^51^107
 ;;^UTILITY(U,$J,358.4,1504,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^52^107
 ;;^UTILITY(U,$J,358.4,1505,0)
 ;;=COMA^20^107
 ;;^UTILITY(U,$J,358.4,1506,0)
 ;;=CAUSES OF INJURY^19^107
 ;;^UTILITY(U,$J,358.4,1507,0)
 ;;=DEMENTIA^21^107
 ;;^UTILITY(U,$J,358.4,1508,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^37^107
 ;;^UTILITY(U,$J,358.4,1509,0)
 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^107
 ;;^UTILITY(U,$J,358.4,1510,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^107
 ;;^UTILITY(U,$J,358.4,1511,0)
 ;;=ACSC ACUTE KIDNEY FAILURE^3^107
 ;;^UTILITY(U,$J,358.4,1512,0)
 ;;=ACSC ANGINA^4^107
 ;;^UTILITY(U,$J,358.4,1513,0)
 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^107
 ;;^UTILITY(U,$J,358.4,1514,0)
 ;;=ACSC CHF^6^107
 ;;^UTILITY(U,$J,358.4,1515,0)
 ;;=ACSC DEHYDRATION^7^107
 ;;^UTILITY(U,$J,358.4,1516,0)
 ;;=ACSC DIABETES TYPE 1^8^107
 ;;^UTILITY(U,$J,358.4,1517,0)
 ;;=ACSC DIABETES TYPE 2^9^107
 ;;^UTILITY(U,$J,358.4,1518,0)
 ;;=ACSC HYPERTENSION^10^107
 ;;^UTILITY(U,$J,358.4,1519,0)
 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^107
 ;;^UTILITY(U,$J,358.4,1520,0)
 ;;=ACSC PNEUMONIA^12^107
 ;;^UTILITY(U,$J,358.4,1521,0)
 ;;=ACSC UTI^13^107
 ;;^UTILITY(U,$J,358.4,1522,0)
 ;;=ACSC VIRAL ENTERITIS^14^107
 ;;^UTILITY(U,$J,358.4,1523,0)
 ;;=E-CIG/VAPE LUNG INJURY^23^107
 ;;^UTILITY(U,$J,358.4,1524,0)
 ;;=COVID-19 CONFIRMED^2^108
 ;;^UTILITY(U,$J,358.4,1525,0)
 ;;=COVID-19 EXPOSURE^3^108
 ;;^UTILITY(U,$J,358.4,1526,0)
 ;;=COVID-19 RELATED COND/SYMP^5^108
 ;;^UTILITY(U,$J,358.4,1527,0)
 ;;=COVID-19 SCREEN^1^108
 ;;^UTILITY(U,$J,358.4,1528,0)
 ;;=COVID-19 PRE-OP^4^108
 ;;^UTILITY(U,$J,358.4,1529,0)
 ;;=COVID-19 VACCINE STATUS^6^108
 ;;^UTILITY(U,$J,358.4,1530,0)
 ;;=COVID-19 ^1^109
 ;;^UTILITY(U,$J,358.4,1531,0)
 ;;=COVID-19 CONFIRMED^2^110
 ;;^UTILITY(U,$J,358.4,1532,0)
 ;;=COVID-19 EXPOSURE^3^110
 ;;^UTILITY(U,$J,358.4,1533,0)
 ;;=COVID-19 RELATED COND/SYMP^5^110
 ;;^UTILITY(U,$J,358.4,1534,0)
 ;;=COVID-19 SCREEN^1^110
 ;;^UTILITY(U,$J,358.4,1535,0)
 ;;=COVID-19 PRE-OP^4^110
 ;;^UTILITY(U,$J,358.4,1536,0)
 ;;=COVID-19 VACCINE STATUS^6^110
